Status:
COMPLETED
Effect of Transcranial Magnetic Stimulation on Cognition and Neural Changes in Parkinson's Disease
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Montreal Neurological Institute and Hospital
McGill University
Conditions:
Parkinson's Disease
Mild Cognitive Impairment
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) affects more than 100,000 Canadians and results in symptoms affecting both motor and cognitive (thinking and memory) functions. Parkinson's disease with Mild Cognitive Impairm...
Detailed Description
Visit 1: Informed Consent Neuropsychological Battery Visit 2: (1-2 days later) Blood Draw Neuropsychiatric Assessment Questionnaires Companion Questionnaire to take home UPDRS Visit 3: (up to a wee...
Eligibility Criteria
Inclusion
- Diagnosis of idiopathic Parkinson's disease any stage
- Mild Cognitive Behaviour confirmed through neuropsychological assessment
- MRI Compatibility
Exclusion
- Alcohol-dependency
- Severe psychiatric disorder, neurological disorder, epilepsy or stroke
- General anaesthesia in the past six months
- History of cerebrovascular disorders
- Colour-blindness
Key Trial Info
Start Date :
October 24 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03243214
Start Date
October 24 2016
End Date
February 14 2020
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary, Department of Clinical Neurosciences
Calgary, Alberta, Canada, T2N 4N1